01 May 2006
Differences in cytochrome P450 2C19 (CYP2C19) expression in adjacent normal and tumor tissues in chinese cancer patients.
Minliang Wu, Shuqing Chen, Xiaohong WuMed Sci Monit 2006; 12(5): BR174-178 :: ID: 450283
Abstract
Background: Cytochrome P450 2C19 (CYP2C19) exhibits polymorphic expressionin humans and deficiencies in its expression have been associated with a number of different cancers.Our aim was to determine if CYP2C19 mRNA and CYP2C19 enzyme protein expression differed between varioustumors and normal tissue adjacent to the tumor tissue in Han Chinese cancer patients. Material/Methods:The level of CYP2C19 mRNA expression was examined in tumor and adjacent normal tissue from liver, colon,stomach, breast, esophagus, lung, uterus, brain, pancreas, ovary, kidney, and several cell lines by semi-quantitativeRT-PCR. Western immunoblots were also used to qualitatively assess CYP2C19 protein in the above tissuesand cell lines. Results: CYP2C19 mRNA was found only in normal livers, hepatic carcinomas, and hepatocarcinomacell lines. The CYP2C19 mRNA was expressed at significantly higher levels in hepatocellular carcinomas(x+/-s: 3.72+/-1.21, n=14) than in adjacent normal liver tissue (x+/-s: 1.79+/-0.33, n=14,p=0.000). CYP2C19 protein was also detected in hepatocarcinoma tissues, adjacent normal tissues, andthe hepatocarcinoma cell lines HepG2, HepGA, and 7721 based on Western blotting methods. These resultsare in accordance with observations employing RT-PCR. Conclusions: CYP2C19 mRNA expression is highestin hepatocarcinoma tissue, moderate in adjacent normal liver tissue, and absent in other cancer tissuesand their adjacent normal tissues. The significantly elevated expression of CYP2C19 mRNA in hepatocarcinomaindicates an association between the occurrence of hepatocarcinoma and the expression and/or turnoverof CYP2C19 mRNA.
Keywords: Reverse Transcriptase Polymerase Chain Reaction, RNA, Neoplasm - metabolism, RNA, Messenger - metabolism, Neoplasms - genetics, Mixed Function Oxygenases - metabolism, Liver - enzymology, Base Sequence, DNA, Complementary - genetics, Carcinoma, Hepatocellular - genetics, Blotting, Western, Aryl Hydrocarbon Hydroxylases - metabolism, Asian Continental Ancestry Group
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
08 Feb 2024 : Database Analysis
Comparative Accuracy of Intraoral and Extraoral Digital Workflows for Short Span Implant Supported Fixed Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943706
08 Feb 2024 : Clinical Research
Serum Selenium Concentration as a Potential Diagnostic Marker for Early-Stage Colorectal Cancer: A Comparat...Med Sci Monit In Press; DOI: 10.12659/MSM.942882
09 Feb 2024 : Clinical Research
Factors Influencing the Occurrence of Intraoperative Hypothermia in Patients Undergoing General Anesthesia ...Med Sci Monit In Press; DOI: 10.12659/MSM.943463
13 Feb 2024 : Clinical Research
A Retrospective Study to Compare the Glasgow Coma Score, Pediatric Trauma Score, and Injury Severity Score ...Med Sci Monit In Press; DOI: 10.12659/MSM.943501
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952